FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1345034008: Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5389614018 Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5389615017 Cytarabine liposome and daunorubicin liposome only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) Is a Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) true Inferred relationship Some
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) Is a Product containing only cytarabine liposome and daunorubicin liposome (medicinal product) true Inferred relationship Some
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) Has active ingredient Cytarabine liposome true Inferred relationship Some 1
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) Has active ingredient Daunorubicin liposome (substance) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Is a True Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) Inferred relationship Some

Reference Sets

GB English

US English

Back to Start